Sanofi India Receives Tax Order Worth ₹14.30 Million

0 min read Updated on 30 Dec 2025, 04:18 PM

Reviewed by

Suketu GScanX News Team

Overview

Sanofi India has received a tax order worth ₹14.30 million from tax authorities, as disclosed in a regulatory filing. This represents a routine regulatory matter that the pharmaceutical company will need to address through appropriate compliance procedures.

*this image is generated using AI for illustrative purposes only.

Sanofi India has received a tax order amounting to ₹14.30 million from tax authorities, the pharmaceutical company disclosed in a regulatory filing.

Tax Order Details

The company has been served with a tax order worth ₹14.30 million, representing a regulatory development that requires the company's attention and response.

Parameter:	Details
Tax Order Amount:	₹14.30 million
Company:	Sanofi India
Nature:	Tax-related proceedings

Regulatory Disclosure

Sanofi India made this disclosure through proper regulatory channels, maintaining transparency with stakeholders regarding the tax order received from authorities.

Company Background

Sanofi India operates in the pharmaceutical sector and is required to comply with various regulatory and tax obligations as part of its business operations in India.

Historical Stock Returns for Sanofi

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.59%	+1.81%	-3.91%	-30.67%	-30.37%	-48.88%

Read Next Article

Sanofi India Receives ₹24.10 Lakh GST Demand Order from Gujarat Tax Authorities

1 min read Updated on 20 Dec 2025, 06:24 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Overview

Sanofi India Limited has received a GST demand order totaling ₹24.10 lakh from the Deputy Commissioner of State Tax, Ahmedabad for FY2018-19, comprising tax of ₹12.96 lakh, interest of ₹9.85 lakh, and penalty of ₹1.30 lakh. The demand relates to excess Input Tax Credit claims in GSTR-3B compared to available ITC in GSTR-2A returns, with the company planning to appeal the decision before higher tax authorities.

*this image is generated using AI for illustrative purposes only.

Sanofi India Limited has received a GST demand order from tax authorities in Ahmedabad, Gujarat, totaling ₹24.10 lakh for the financial year 2018-19. The pharmaceutical company disclosed this development in compliance with SEBI listing regulations on December 24, 2025.

Order Details and Timeline

The Deputy Commissioner of State Tax, Ahmedabad, Gujarat issued the order dated December 23, 2025, which was received by Sanofi India on the same day. The demand notice pertains to GST-related issues from FY2018-19.

Component:	Amount
Tax:	₹12.96 lakh
Interest:	₹9.85 lakh
Penalty:	₹1.30 lakh
Total Demand:	₹24.10 lakh

Nature of Violations

The tax authorities have raised the demand due to excess claim of Input Tax Credit (ITC) in GSTR-3B returns as compared to ITC available in GSTR-2A returns. The Adjudicating/Assessing authority has denied the excess ITC claim, leading to the current dispute with tax authorities.

Company's Response

Sanofi India has indicated that it plans to challenge the order through proper legal channels. The company stated it would make an appeal before the Higher Tax Authorities, suggesting it disputes the findings and demands made in the order.

The pharmaceutical company has assessed that there is no quantifiable impact on its financial, operational, or other activities at this stage, indicating the matter is being treated as a routine compliance issue subject to appeal.

Regulatory Compliance

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation requires listed companies to inform stock exchanges about material events that could impact investor decisions.

The company secretary and compliance officer, Haresh Vala, signed the disclosure notice submitted to both BSE Limited and National Stock Exchange of India Limited on December 24, 2025.

Historical Stock Returns for Sanofi